ES2065992T3 - Uso de derivados de imidazopirazol como analgesicos y agentes anti-inflamatorios. - Google Patents

Uso de derivados de imidazopirazol como analgesicos y agentes anti-inflamatorios.

Info

Publication number
ES2065992T3
ES2065992T3 ES89307596T ES89307596T ES2065992T3 ES 2065992 T3 ES2065992 T3 ES 2065992T3 ES 89307596 T ES89307596 T ES 89307596T ES 89307596 T ES89307596 T ES 89307596T ES 2065992 T3 ES2065992 T3 ES 2065992T3
Authority
ES
Spain
Prior art keywords
analgesics
inflammatory agents
aralkyl
hydrogen
heterociclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89307596T
Other languages
English (en)
Inventor
Atsusuke C O Sankyo Com Terada
Kazuyuki C O Sankyo Comp Wachi
Hachio C O Sankyo Com Miyazawa
Yoshio C O Sankyo Compa Iizuka
Keiichi C O Sankyo Comp Tabata
Kazuo C O Sankyo Comp Hasegawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2065992T3 publication Critical patent/ES2065992T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
    • F16B17/00—Connecting constructional elements or machine parts by a part of or on one member entering a hole in the other and involving plastic deformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

COMPUESTOS DE FORMULA (I), DONDE R1 Y R2 SON HIDROGENO, ALQUILO OPCIONALMENTE SUSTITUIDO, CICLOALQUILO, ALQUENILO, ARALQUILO, ARILALQUENILO, ARILO, HETEROCICLILO AROMATICO, CIANO O HALOGENO; R3 ES HIDROGENO, ALQUILO OPCIONALMENTE SUSTITUIDO, ARALQUILO O ACILO; R4 Y R5 SON HIDROGENO, ALQUILO OPCIONALMENTE SUSTITUIDO, CICLOALQUILO, ALQUENILO, ARALQUILO, ARILALQUENILO, ARILO O HETEROCICLILO AROMATICO; Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, SON ANALGESICOS Y AGENTES ANTIINFLAMATORIOS, QUE TIENEN TAMBIEN ACTIVIDADES ANTIULCEROSAS E INHIBIDORAS DE 5-LIPOXIGENASA.
ES89307596T 1988-07-26 1989-07-26 Uso de derivados de imidazopirazol como analgesicos y agentes anti-inflamatorios. Expired - Lifetime ES2065992T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18613288 1988-07-26

Publications (1)

Publication Number Publication Date
ES2065992T3 true ES2065992T3 (es) 1995-03-01

Family

ID=16182931

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89307596T Expired - Lifetime ES2065992T3 (es) 1988-07-26 1989-07-26 Uso de derivados de imidazopirazol como analgesicos y agentes anti-inflamatorios.

Country Status (14)

Country Link
EP (1) EP0353047B1 (es)
JP (1) JPH0753730B2 (es)
KR (1) KR940009785B1 (es)
CN (2) CN1032207C (es)
AT (1) ATE112569T1 (es)
CA (1) CA1340444C (es)
DE (1) DE68918651T2 (es)
DK (1) DK369289A (es)
ES (1) ES2065992T3 (es)
FI (1) FI91871C (es)
HK (1) HK1005732A1 (es)
IE (1) IE68940B1 (es)
NO (1) NO171639C (es)
ZA (1) ZA895670B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
DE10019714A1 (de) * 2000-04-20 2002-01-10 Gruenenthal Gmbh Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen
ES2632220T3 (es) * 2009-06-15 2017-09-11 Rigel Pharmaceuticals, Inc. Inhibidores de moléculas pequeñas de tirosina cinasa del bazo (SYK)
CN101671336B (zh) * 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途
EP2807162B1 (de) * 2012-01-25 2017-06-07 Bayer Pharma Aktiengesellschaft Substituierte phenylimidazopyrazole und ihre verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2116971B (en) * 1982-03-16 1985-03-27 Erba Farmitalia Substituted 1h-pyrazolo (1 5-a) pyrimidines and process for their preparation
JPH0231374B2 (ja) * 1983-08-08 1990-07-12 Fuji Photo Film Co Ltd Harogenkaginkaraakankozairyo
GB8426447D0 (en) * 1984-10-19 1984-11-28 Kodak Ltd Photographic colour couplers

Also Published As

Publication number Publication date
ZA895670B (en) 1991-03-27
CN1034333C (zh) 1997-03-26
JPH0753730B2 (ja) 1995-06-07
NO171639C (no) 1993-04-14
KR940009785B1 (ko) 1994-10-17
IE892428L (en) 1990-01-26
DK369289D0 (da) 1989-07-26
NO171639B (no) 1993-01-04
KR900001701A (ko) 1990-02-27
FI893570A0 (fi) 1989-07-26
EP0353047A2 (en) 1990-01-31
CN1040196A (zh) 1990-03-07
ATE112569T1 (de) 1994-10-15
HK1005732A1 (en) 1999-01-22
NO893039D0 (no) 1989-07-26
CA1340444C (en) 1999-03-16
DE68918651T2 (de) 1995-05-24
DK369289A (da) 1990-01-27
CN1032207C (zh) 1996-07-03
EP0353047B1 (en) 1994-10-05
FI91871B (fi) 1994-05-13
NO893039L (no) 1990-01-29
EP0353047A3 (en) 1991-07-24
DE68918651D1 (de) 1994-11-10
CN1094049A (zh) 1994-10-26
JPH02124889A (ja) 1990-05-14
IE68940B1 (en) 1996-07-24
FI893570A7 (fi) 1990-01-27
FI91871C (fi) 1994-08-25

Similar Documents

Publication Publication Date Title
ES2176204T3 (es) Antidepresivos que contienen un derivado de xantina.
DK51986A (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som insecticide midler
ES2062009T4 (es) Agentes antifungicos derivados de triazol
AR006390A1 (es) Derivados de lactama
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
DK0625977T3 (da) Piperazinderivater som 5-1A-antagonister
DE3852565D1 (de) Aryl-heteroaryl-karbinol-Derivate mit analgetischer Aktivität.
UY24010A1 (es) Nuevos pirrolocarbazoles
AR025796A1 (es) Quinazolinonas
UY25211A1 (es) Inhibidores de isoquinolinilguanidina uroquinasa
ES2037257T3 (es) Procedimiento de obtencion de los derivados de n-aminobutil y n-fenil arilamidas.
ES2123756T3 (es) Derivados de piperazina.
ATE421524T1 (de) 5-ring-heterocyclen, ihre herstellung, ihre verwendung als inhibitoren der leukozytenadhäsion und sie enthaltende pharmazeutische präparate
AR025797A1 (es) Quinazolinonas
ES2037011T3 (es) Procedimiento para la preparacion de nuevos derivados de benzofuran-2-il-imidazol.
ES2158290T3 (es) Derivados de tiazolidinona opticamente activos.
DK369289A (da) Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler
DK0667863T3 (da) 2-Perhalogenalkyl-substituerede benzimidazoler, deres fremstilling samt deres anvendelse som pesticider
ES2058542T3 (es) Imidas biciclicas puenteadas de 4-(4-(3-benzoisotiazolil)-1-piperazinil)butilo antipsicoticas.
ATE47841T1 (de) 5-sulfonamido-1-aryl-pyrazole.
AR010550A1 (es) Derivados de cefalosporina, su uso, proceso para fabricarlos y preparaciones farmaceuticas que los contienen.
ES2120885B1 (es) Nuevas tienopirimidonas con actividad antifungica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 353047

Country of ref document: ES